ConductScience.org, home

Trial · NCT07902466

Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral Palsy

NCT07902466, Not applicable, Recruiting, LIFE - Research and Care Institute - Santa Lucia IRCCS

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral Palsy. Trials, record NCT07902466. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902466

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral Palsy
NCT number
NCT07902466
Status
Recruiting
Phases
Not applicable
Enrollment
20 participants, estimated
Lead sponsor
LIFE - Research and Care Institute - Santa Lucia IRCCS
Conditions
Cerebral Palsy (CP), Unilateral Spastic Cerebral Palsy, Bilateral Spastic Cerebral Palsy, Diplegic Cerebral Palsy With Spasticity, Hemiplegic Cerebral Palsy
Interventions
Manual Therapy (T1 & T3)
First posted
2026-10-28
Last updated
2026-10-28

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Walking Speed via Instrumental Gait Analysis
Measured at T0 (Baseline, before intervention period), T1 (Immediate post-Manual Therapy, week 1), T2 (Immediate post-Functional Therapy, week 2), and T3 (Immediate post-Combined Therapy, week 3), over a total study duration of 4 weeks.
Evaluation of walking speed measured in meters per second (m/s) using 3D motion analysis systems.
SecondaryChange in Step Length via Instrumental Gait Analysis
Measured at T0 (Baseline, before intervention period), T1 (Immediate post-Manual Therapy, week 1), T2 (Immediate post-Functional Therapy, week 2), and T3 (Immediate post-Combined Therapy, week 3), over a total study duration of 4 weeks.
Evaluation of step length measured in meters (m) using 3D motion analysis systems
SecondaryChange in Cadence via Instrumental Gait Analysis
Measured at T0 (Baseline, before intervention period), T1 (Immediate post-Manual Therapy, week 1), T2 (Immediate post-Functional Therapy, week 2), and T3 (Immediate post-Combined Therapy, week 3), over a total study duration of 4 weeks
Evaluation of cadence measured in steps per minute (steps/min) using 3D motion analysis systems
SecondaryChange in Double Support Time via Instrumental Gait Analysis
Measured at T0 (Baseline, before intervention period), T1 (Immediate post-Manual Therapy, week 1), T2 (Immediate post-Functional Therapy, week 2), and T3 (Immediate post-Combined Therapy, week 3), over a total study duration of 4 weeks
Evaluation of double support time measured as a percentage of the gait cycle (% of gait cycle) using 3D motion analysis systems
SecondaryChange in Joint and Elevation Angles via Instrumental Gait Analysis
Measured at T0 (Baseline, before intervention period), T1 (Immediate post-Manual Therapy, week 1), T2 (Immediate post-Functional Therapy, week 2), and T3 (Immediate post-Combined Therapy, week 3), over a total study duration of 4 weeks
Evaluation of joint angles, elevation angles, and foot lift measured in degrees using 3D motion analysis systems
SecondaryChange in Electromyographic (EMG) Activity Parameters
Measured at T0 (Baseline, before intervention period), T1 (Immediate post-Manual Therapy, week 1), T2 (Immediate post-Functional Therapy, week 2), and T3 (Immediate post-Combined Therapy, week 3), over a total study duration of 4 weeks
Evaluation of center of activity of EMG signals, FWHM (full width at half maximum), coactivation index, and mean intensity of EMG signals using 3D motion analysis systems

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers13

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
14155190BACKGROUNDPubMed
22925609BACKGROUNDPubMed
23139425BACKGROUNDPubMed
24989994BACKGROUNDPubMed
28698802BACKGROUNDPubMed
30228805BACKGROUNDPubMed
30753998BACKGROUNDPubMed
31677546BACKGROUNDPubMed
32961844BACKGROUNDPubMed
37305763BACKGROUNDPubMed

1 to 10 of 13

See all 13 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07902466

GET https://conductscience.org/api/trials/v1/NCT07902466/registered